Roxithromycin capsule can treat bronchitis, but it should be judged according to the specific type of pathogenic bacteria.
Roxithromycin capsule is a new generation of macrolide antibiotics, suitable for the treatment of pharyngitis or tonsillitis caused by Streptococcus pyogenes, acute and chronic bronchitis caused by sensitive bacteria, otitis media, sinusitis, pneumonia caused by Mycoplasma pneumoniae or Chlamydia pneumoniae, chlamydia trachomatis caused by urethritis or cervicitis.
If the patient suffers from bronchitis caused by sensitive bacteria, mycoplasma or chlamydia, the choice of roxithromycin capsule is symptomatic treatment, and will have a better therapeutic effect after taking.
If the causative organisms are not sensitive to erythromycin, or drug-resistant, the effect of erythromycin capsules is not good.
It should be noted that after taking the drug may appear nausea, vomiting, abdominal pain, diarrhea, skin rash and other adverse reactions. Allergic to the drug is prohibited, contraindicated with ergotamine and dihydroergotamine, hepatic and renal insufficiency, pregnant women, lactating women with caution.
Therefore, it is recommended that patients go to a regular hospital for examination, to clarify the type of pathogenic bacteria, to take symptomatic drug treatment, so as not to delay the condition.